CD5L:p40, a novel heterodimeric regulator of type 2 inflammation. - Wang C; Zaghouani S; Wallrapp A; Newcomer K; Greenfield E; Johnson JB; Barilla R; Pawlak M; Christian E; Burkett PR; Leabo M; Li P; et al. (Journal of immunology (Baltimore, Md. : 1950), 2026)